Medicare AdvantageCoverageMedium impact
Ocular Surface Disease Diagnosis and Treatments - Medicare Advantage (Revised)
Humana·Ophthalmology, Optometry·Medicare Advantage
We identified it
Jul 2, 2026
Summary
This is a revised Medicare Advantage policy for Ocular Surface Disease (OSD) diagnosis and treatment coverage. The policy defines OSD as a multifactorial condition affecting tear film and ocular surfaces, including associated dry eye disease and Sjögren's disease. The complete policy details regarding coverage criteria, approved treatments, and billing requirements are not fully visible in this summary excerpt.
Action Required
URGENT: Billing team must obtain the complete policy document from the provided Humana source URL immediately. The summary provided is incomplete and cuts off mid-sentence, preventing full analysis of coverage requirements, prior authorization needs, and specific billing codes affected. Contact Humana directly at https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a569993 or your Humana representative to retrieve the full policy text. Once obtained, identify all specific CPT, HCPCS, and ICD-10 codes referenced and determine if prior authorization is required for OSD diagnoses and treatments. Update billing workflows, encounter forms, and clinical staff training based on the complete policy guidance. Do not delay—this policy is 1 day old and represents active Medicare Advantage coverage guidance.